Collective Claim

US legal-information publication

Collective Claim

Collective Claim publishes sourced, plain-language information about US mass tort, product liability and consumer litigation.

Every article states what a court, agency or filing has actually done, labels allegations as allegations, and links to the primary documents. We do not sell case reviews, and we are not a law firm.

The Collective Claim masthead card, reading Collective Claim and US mass tort and consumer litigation.
The Collective Claim masthead card, reading Collective Claim and US mass tort and consumer litigation.

Browse by topic

Mass Tort Litigation Plain-language information about US mass tort litigation: how coordinated federal proceedings work, what institutional abuse claims involve, … 9 articles Pharmaceutical Lawsuits Information about US litigation over prescription medicines: label changes, withdrawals, safety communications, and how consolidated federal … 15 articles Product Liability How US product liability claims work: manufacturing and design defects, failure-to-warn allegations, recalls, and the consolidated … 13 articles Medical Device Litigation Information about US litigation over medical devices: FDA recalls and safety communications, premarket approval and preemption, and how … 12 articles Environmental Litigation US environmental litigation explained: contaminated water and soil claims, PFAS and asbestos exposure, agency standards, and how … 2 articles Personal Injury Claims How US personal injury claims work: negligence, comparative fault, damages, insurance, filing deadlines and the evidence that decides a … 1 article Class Actions How US class actions work: Rule 23 certification, opt-out rights, settlements and cy pres awards, plus current consumer and platform-safety … 5 articles Legal Guides Explanatory guides to US civil procedure and mass tort practice: how multidistrict litigation works, how it differs from a class action, and … 6 articles

Latest articles

Product Liability

Kia and Hyundai Theft Claims: MDL 3052 Status

Federal Kia and Hyundai theft claims are consolidated as MDL 3052. A $145 million class settlement is approved but on appeal, and insurer claims continue.

9 min read

All articles

How this publication works

Sourced, not asserted

Claims are tied to primary documents: FDA and CPSC actions, court dockets, JPML orders, statutes and official settlement notices. Secondary reporting is labelled.

Editorial policy

Allegations stay allegations

An allegation in a complaint is described as an allegation. Verdicts, settlements and regulatory findings are described as what they are, with dates and the deciding body named.

About Collective Claim

Corrections in the open

Substantive corrections are logged on the article and summarised on the corrections page, with the date and what changed.

Corrections policy

Tell us about your situation

Share a few details so a law firm that handles this kind of case can consider them. Submitting this form does not create an attorney–client relationship, does not mean a claim exists, and does not guarantee representation or compensation. We are not a law firm and cannot advise you. Corrections, source documents and press enquiries come through the same form.

Step 1 of 4

What is your message about?

Choose the closest match. You can change it at any point.

Who should we reply to?

Required, so that a firm reviewing your inquiry can reach you. Give the number you actually answer.

Your message

A short summary is enough. If you are reporting a correction, name the article and the sentence.

Please do not send confidential or privileged information. This form is not encrypted end to end, and nothing sent through it is protected by attorney–client privilege. Do not include medical records, Social Security or account numbers, or details you would only share with your own lawyer. Link to a public document instead.

Check and send
About
—
Name
—
Email
—
Phone
—
Message
—

Use Back to change anything before sending.

We use what you send only to answer you and, where relevant, to correct or source an article. We do not add you to a mailing list, we do not sell or share your details, and we do not pass them to lawyers or claims companies. See the privacy policy and what we can and cannot help with.